Inge van Rossum
Affiliation: Eli Lilly and Company
- [The influence of cannabis on the course of bipolar disorder: a longitudinal analysis]I Winter-van Rossum
Lilly Nederland B V, Houten
Tijdschr Psychiatr 52:287-98. 2010..Research shows that the use of cannabis has a negative impact on the onset and outcome of schizophrenia, but little is known about possible effects on mood disorders...
- Bipolar disorder and dopamine dysfunction: an indirect approach focusing on tardive movement syndromes in a naturalistic settingInge van Rossum
Eli Lilly Nederland, Medical Department, Houten, The Netherlands
BMC Psychiatry 9:16. 2009..An indirect approach to examine this issue was developed, focusing on associations between dopamine proxy measures observed in BD (dopamine-related clinical traits using tardive movement syndromes as dopamine proxy measure of reference)...
- Does cannabis use affect treatment outcome in bipolar disorder? A longitudinal analysisInge van Rossum
Medical Department, Eli Lilly Nederland, Houten, The Netherlands
J Nerv Ment Dis 197:35-40. 2009..An independent impact of cannabis use on psychopathologic outcomes in patients with bipolar disorder was apparent, whereas the impact on social outcomes was modest...
- Stability and treatment outcome of distinct classes of maniaInge van Rossum
Medical Department, Eli Lilly Nederland, Grootslag 1 5, Houten, The Netherlands
Eur Psychiatry 23:360-7. 2008..Differential treatment course and outcome after 12 weeks of treatment were examined for three distinct classes of patients with acute mania in bipolar disorder...